Gene · 5052
Papers3,897
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,897
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nanomaterial-Based Drug Delivery Systems for Ischemic Stroke: From Blood-Brain Barrier Crossing to Neuroprotection. | Int J Nanomedicine | 2026 | 41710368 | PubTator, text mining | PubMed |
| Methionine restriction in cancer: a dietary insight for therapy. | Front Nutr | 2026 | 41710278 | PubTator, text mining | PubMed |
| Effects of ascorbic acid on trabecular meshwork gene expression and collagen secretion. | BMJ Open Ophthalmol | 2026 | 41692493 | PubTator, text mining | PubMed |
| Ginsenoside Rg5 Targets PRDX1 to Disrupt Redox Homeostasis and Induce Mitochondria-Dependent Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells. | Molecules | 2026 | 41683534 | PubTator, text mining | PubMed |
| Top-Down Proteomics in the Assessment of Kidney Donor Quality: a novel approach to increased organ utilization. | medRxiv | 2026 | 41674647 | PubTator, text mining | PubMed |
| Plasma Proteome Profiling of Centenarian Across Switzerland Reveals Key Youth-Associated Proteins. | Aging Cell | 2026 | 41655127 | PubTator, text mining | PubMed |
| Study on the differential expression of disulfidptosis-related genes and their association with immune regulation in patients with diabetic retinopathy. | Sci Rep | 2026 | 41651978 | PubTator, text mining | PubMed |
| Hallmarks of nuclear metabolism: implications for genome integrity, nuclear signaling, and therapeutic targeting. | NPJ Metab Health Dis | 2026 | 41629581 | PubTator, text mining | PubMed |
| A protein-based pneumococcal vaccine elicits broad immunity associated with multifunctional antibody responses in humans. | J Clin Invest | 2026 | 41623167 | PubTator, text mining | PubMed |
| An elastase-responsive "plug-and-play" quercetin-loaded engineered extracellular vesicle platform anchored with anti-PRDX1 antibody for severe acute pancreatitis therapy. | J Control Release | 2026 | 41621758 | PubTator, text mining | PubMed |
| Peroxiredoxin 2 contributes to the malignant phenotype of glioblastoma cells. | Biochem Biophys Res Commun | 2026 | 41619511 | PubTator, text mining | PubMed |
| Unlocking Ethiopia's genomic landscape and its global significance: a call for inclusive genomics research. | Hum Genomics | 2026 | 41612491 | PubTator, text mining | PubMed |
| Lipopolysaccharide Upregulates Neuroinflammation, Oxidative Stress Responses, and Peroxiredoxins in Depression Models. | Brain Behav | 2026 | 41603055 | PubTator, text mining | PubMed |
| Lactate-lactylation in tumor angiogenesis and progression: mechanisms, biomarker potential, and therapeutic implications. | Biomark Res | 2026 | 41593811 | PubTator, text mining | PubMed |
| CRISPR-based chemogenomic profiling reveals redox vulnerabilities to epigallocatechin-3-gallate and green tea polyphenol extract. | Redox Biol | 2026 | 41581373 | PubTator, text mining | PubMed |
| Single-cell transcriptomics uncovers malignant potential of gallbladder adenomyomatosis and identifies PRDX1+ immunosuppressive macrophages in gallbladder carcinoma. | Int J Surg | 2026 | 41570280 | PubTator, text mining | PubMed |
| SLC25A39 binds and modulates PRDX1 to suppress ROS-induced necroptosis in hepatocellular carcinoma. | Int Immunopharmacol | 2026 | 41558298 | PubTator, text mining | PubMed |
| Peroxiredoxin 1, pyroptosis, and the emerging frontier in colorectal cancer therapy. | World J Gastroenterol | 2026 | 41551531 | PubTator, text mining | PubMed |
| Oxidative stress-driven transcriptomic remodeling in human astrocytes reveals network signatures associated with neurodegenerative and cardiovascular processes. | Comput Struct Biotechnol J | 2026 | 41550140 | PubTator, text mining | PubMed |
| Nrf2-ARE signaling pathway as a key regulator of oxidative stress and antioxidant responses in granulosa cells in polycystic ovary syndrome. | Clin Exp Reprod Med | 2026 | 41485788 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5052/papers?page=5